BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22115786)

  • 1. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase.
    Kaku Y; Noguchi A; Marsh GA; Barr JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
    J Virol Methods; 2012 Jan; 179(1):226-32. PubMed ID: 22115786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein.
    Kaku Y; Noguchi A; Marsh GA; McEachern JA; Okutani A; Hotta K; Bazartseren B; Fukushi S; Broder CC; Yamada A; Inoue S; Wang LF
    J Virol Methods; 2009 Sep; 160(1-2):7-13. PubMed ID: 19433112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a neutralization assay for Nipah virus using pseudotype particles.
    Tamin A; Harcourt BH; Lo MK; Roth JA; Wolf MC; Lee B; Weingartl H; Audonnet JC; Bellini WJ; Rota PA
    J Virol Methods; 2009 Sep; 160(1-2):1-6. PubMed ID: 19559943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody.
    Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB
    Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdovirus-based vaccine platforms against henipaviruses.
    Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
    J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
    Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
    J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
    Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
    PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of human complement with virus particles containing the Nipah virus glycoproteins.
    Johnson JB; Aguilar HC; Lee B; Parks GD
    J Virol; 2011 Jun; 85(12):5940-8. PubMed ID: 21450814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.
    Kemp TJ; Matsui K; Shelton G; Safaeian M; Pinto LA
    Hum Vaccin Immunother; 2015; 11(2):337-46. PubMed ID: 25695397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein.
    Tani H; Kimura M; Tan L; Yoshida Y; Ozawa T; Kishi H; Fukushi S; Saijo M; Sano K; Suzuki T; Kawasuji H; Ueno A; Miyajima Y; Fukui Y; Sakamaki I; Yamamoto Y; Morinaga Y
    Virol J; 2021 Jan; 18(1):16. PubMed ID: 33435994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
    Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
    J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers.
    Vandergaast R; Carey T; Reiter S; Lathrum C; Lech P; Gnanadurai C; Haselton M; Buehler J; Narjari R; Schnebeck L; Roesler A; Sevola K; Suksanpaisan L; Bexon A; Naik S; Brunton B; Weaver SC; Rafael G; Tran S; Baum A; Kyratsous CA; Peng KW; Russell SJ
    mSphere; 2021 Jun; 6(3):e0017021. PubMed ID: 34077262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system.
    Khetawat D; Broder CC
    Virol J; 2010 Nov; 7():312. PubMed ID: 21073718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.
    Di Rubbo A; McNabb L; Klein R; White JR; Colling A; Dimitrov DS; Broder CC; Middleton D; Lunt RA
    J Virol Methods; 2019 Dec; 274():113731. PubMed ID: 31513861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.
    DeBuysscher BL; Scott D; Marzi A; Prescott J; Feldmann H
    Vaccine; 2014 May; 32(22):2637-44. PubMed ID: 24631094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for henipavirus spillover into human populations in Africa.
    Pernet O; Schneider BS; Beaty SM; LeBreton M; Yun TE; Park A; Zachariah TT; Bowden TA; Hitchens P; Ramirez CM; Daszak P; Mazet J; Freiberg AN; Wolfe ND; Lee B
    Nat Commun; 2014 Nov; 5():5342. PubMed ID: 25405640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses.
    Amaya M; Yin R; Yan L; Borisevich V; Adhikari BN; Bennett A; Malagon F; Cer RZ; Bishop-Lilly KA; Dimitrov AS; Cross RW; Geisbert TW; Broder CC
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus.
    McNabb L; Barr J; Crameri G; Juzva S; Riddell S; Colling A; Boyd V; Broder C; Wang LF; Lunt R
    J Virol Methods; 2014 May; 200():22-8. PubMed ID: 24508193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.